These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 15937348)
21. Unique strengths of ELISPOT for T cell diagnostics. Lehmann PV; Zhang W Methods Mol Biol; 2012; 792():3-23. PubMed ID: 21956497 [TBL] [Abstract][Full Text] [Related]
22. Improving the sensitivity of the ELISPOT analyses of antigen-specific cellular immune responses in rhesus macaques. Sastry KJ; Nehete PN; Nehete B Methods Mol Biol; 2005; 302():153-66. PubMed ID: 15937350 [TBL] [Abstract][Full Text] [Related]
23. ELISPOT and intracellular cytokine staining: novel assays for quantifying T cell responses in the chicken. Ariaans MP; van de Haar PM; Lowenthal JW; van Eden W; Hensen EJ; Vervelde L Dev Comp Immunol; 2008; 32(11):1398-404. PubMed ID: 18579202 [TBL] [Abstract][Full Text] [Related]
24. Methods for quantitating antigen-specific T cell responses using functional assays in rhesus macaques. Amara RR Methods Mol Biol; 2009; 485():417-24. PubMed ID: 19020841 [TBL] [Abstract][Full Text] [Related]
25. Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment. Vassilopoulos D; Stamoulis N; Hadziyannis E; Archimandritis AJ J Rheumatol; 2008 Jul; 35(7):1271-6. PubMed ID: 18381793 [TBL] [Abstract][Full Text] [Related]
26. Modified ELISPOT technique--highly significant inverse correlation of post-Tx donor-reactive IFNgamma-producing cell frequencies with 6 and 12 months graft function in kidney transplant recipients. Näther BJ; Nickel P; Bold G; Presber F; Schönemann C; Pratschke J; Volk HD; Reinke P Transpl Immunol; 2006 Nov; 16(3-4):232-7. PubMed ID: 17138059 [TBL] [Abstract][Full Text] [Related]
27. Definition of an immunologic response using the major histocompatibility complex tetramer and enzyme-linked immunospot assays. Comin-Anduix B; Gualberto A; Glaspy JA; Seja E; Ontiveros M; Reardon DL; Renteria R; Englahner B; Economou JS; Gomez-Navarro J; Ribas A Clin Cancer Res; 2006 Jan; 12(1):107-16. PubMed ID: 16397031 [TBL] [Abstract][Full Text] [Related]
29. Quantification of IFN-gamma produced by human purified NK cells following tumor cell stimulation: comparison of three IFN-gamma assays. Lion E; Smits EL; Berneman ZN; Van Tendeloo VF J Immunol Methods; 2009 Oct; 350(1-2):89-96. PubMed ID: 19733573 [TBL] [Abstract][Full Text] [Related]
30. ELISPOT determination of interferon-gamma T-cell frequencies in patients with autoimmune sensorineural hearing loss. Solares CA; Tuohy VK Methods Mol Biol; 2005; 302():253-60. PubMed ID: 15937357 [TBL] [Abstract][Full Text] [Related]
31. Restoration in vitro of impaired T-cell responses in patients with chronic hepatitis B by autologous dendritic cells loaded with hepatitis B virus proteins (R2). Duan XZ; He HX; Zhuang H J Gastroenterol Hepatol; 2006 Jun; 21(6):970-6. PubMed ID: 16724980 [TBL] [Abstract][Full Text] [Related]
32. Defective gammadelta T-cell function and granzyme B gene polymorphism in a cohort of newly diagnosed breast cancer patients. Gaafar A; Aljurf MD; Al-Sulaiman A; Iqniebi A; Manogaran PS; Mohamed GE; Al-Sayed A; Alzahrani H; Alsharif F; Mohareb F; Ajarim D; Tabakhi A; Al-Hussein K Exp Hematol; 2009 Jul; 37(7):838-48. PubMed ID: 19446661 [TBL] [Abstract][Full Text] [Related]
33. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behçet's disease. Akman A; Sallakci N; Coskun M; Bacanli A; Yavuzer U; Alpsoy E; Yegin O Br J Dermatol; 2006 Aug; 155(2):350-6. PubMed ID: 16882174 [TBL] [Abstract][Full Text] [Related]
34. Evaluating antigen-specific cytotoxic T lymphocyte responses by a novel mouse granzyme B ELISPOT assay. Ewen CL; Rong J; Kokaji AI; Bleackley RC; Kane KP J Immunol Methods; 2006 Jan; 308(1-2):156-66. PubMed ID: 16375915 [TBL] [Abstract][Full Text] [Related]
35. Pretransplant donor-specific interferon-gamma ELISPOT assay predicts acute rejection episodes in renal transplant recipients. Kim SH; Oh EJ; Kim MJ; Park YJ; Han K; Yang HJ; Kim JY; Choi BS; Yang CW; Kim YS; Bang BK Transplant Proc; 2007 Dec; 39(10):3057-60. PubMed ID: 18089321 [TBL] [Abstract][Full Text] [Related]
36. The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT. Kutscher S; Dembek CJ; Allgayer S; Heltai S; Stadlbauer B; Biswas P; Nozza S; Tambussi G; Bogner JR; Stellbrink HJ; Goebel FD; Lusso P; Tinelli M; Poli G; Erfle V; Pohla H; Malnati M; Cosma A AIDS Res Ther; 2008 Oct; 5():22. PubMed ID: 18837993 [TBL] [Abstract][Full Text] [Related]
37. [Evolution of IGRA researches]. Ariga H; Harada N Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999 [TBL] [Abstract][Full Text] [Related]
38. Rapid diagnosis of tuberculous pleuritis by a T-cell interferon-gamma release assay. Kobashi Y; Shimizu H; Mouri K; Obase Y; Miyashita N; Oka M Scand J Infect Dis; 2009; 41(3):232-6. PubMed ID: 19107640 [TBL] [Abstract][Full Text] [Related]
39. Granulocyte contamination dramatically inhibits spot formation in AIDS virus-specific ELISpot assays: analysis and strategies to ameliorate. De Rose R; Taylor EL; Law MG; van der Meide PH; Kent SJ J Immunol Methods; 2005 Feb; 297(1-2):177-86. PubMed ID: 15777941 [TBL] [Abstract][Full Text] [Related]
40. Statistical evaluation for detection of peptide specific interferon-gamma secreting T-cells induced by HIV vaccine determined by ELISPOT assay. Periwal SB; Spagna K; Shahabi V; Quiroz J; Shroff KE J Immunol Methods; 2005 Oct; 305(2):128-34. PubMed ID: 16181634 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]